Health – WHO Europe Names Denmark Institute as Key Disease Partner
Health – The World Health Organization’s regional office for Europe has appointed Denmark’s Centre for Health and Infectious Disease Research as a collaborating centre to strengthen efforts against major infectious diseases across the region. The designation is expected to enhance coordination and improve practical implementation of health strategies among member countries.
New role to support regional health systems
The centre, known as CHIP and based at Rigshospitalet in partnership with the University of Copenhagen, will work closely with World Health Organization Europe to support national health authorities. Its role will include translating scientific findings into real-world public health actions, improving preparedness, and helping countries meet agreed health targets.
Officials say the collaboration will focus on strengthening responses to HIV, tuberculosis, viral hepatitis, and sexually transmitted infections. The initiative reflects a broader effort to address persistent gaps in testing, treatment, and prevention across the region.
Focus on workforce and access to testing
Over the next four years, the Danish centre is expected to play a key role in building healthcare capacity. This includes training professionals, improving diagnostic access, and supporting research that informs policy decisions.
Efforts will also concentrate on expanding testing services for HIV, hepatitis, and other infections, particularly in underserved populations. By improving early detection, health systems can respond faster and reduce long-term complications.
Another important objective is to refine biomedical prevention programmes. These include strategies such as preventive treatments and targeted interventions aimed at reducing transmission rates.
Strengthening technical expertise across countries
Health officials highlighted that collaborating centres extend the technical reach of WHO by offering specialised knowledge and institutional support. This helps countries respond more effectively to emerging and ongoing health challenges.
According to regional health experts, partnerships like this allow for better sharing of expertise and resources. They also promote consistency in how diseases are managed across borders, which is especially important for infections that spread internationally.
Understanding the diseases in focus
HIV remains a significant global health concern, as it attacks the immune system and weakens the body’s ability to fight infections. Without treatment, it can progress to advanced stages that are life-threatening. However, modern antiretroviral therapy enables people living with HIV to maintain long and stable lives.
Viral hepatitis, another key focus area, involves inflammation of the liver and can result from several causes, including viral infections. Some forms can be prevented through vaccination, while others require long-term medical management.
Tuberculosis continues to pose serious risks, particularly because it spreads through the air and primarily affects the lungs. Though treatable, it requires consistent medication over several months. Interruptions in treatment can lead to drug-resistant strains, making control more difficult.
Sexually transmitted infections also remain a public health priority due to their widespread impact and potential complications if left untreated. Increasing awareness and access to care are considered essential to reducing their prevalence.
A step toward coordinated regional action
The appointment of the Danish research centre signals a renewed push for coordinated action in tackling infectious diseases across Europe. By combining research, clinical expertise, and policy support, the initiative aims to create stronger, more resilient health systems.
Authorities believe that sustained collaboration will be crucial in addressing both current and future public health challenges, ensuring that scientific advancements translate into meaningful outcomes for communities.